首页> 外文期刊>British Journal of Radiology >Image-guided volumetric modulated arc therapy for breast cancer: A feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy
【24h】

Image-guided volumetric modulated arc therapy for breast cancer: A feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy

机译:图像引导的体积调制弧光治疗乳腺癌:与三维共形和强度调制放射治疗的可行性研究和计划比较

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To test the feasibility of volumetric modulated arc therapy (VMAT) in breast cancer and to compare it with three-dimensional conformal radiotherapy (3D-CRT) as conventional tangential field radiotheraphy ( conTFRT). Methods: 12 patients (Stage 1, 8: 6 left breast cancer and 2 right breast cancer; Stage 2, 4: 2 on each side). Three plans were calculated for each case after breast-conserving surgery. Breast was treated with 50Gy in four patients with supraclavicular lymph node inclusion, and in eight patients without the node inclusion. Multiple indices and dose parameters were measured. Results: V95% was not achieved by any modality. Heterogeneity index: 0.16 (VMAT), 0.13 [intensity-modulated radiotherapy (IMRT)] and 0.14 ( conTFRT). Conformity index: 1.06 (VMAT), 1.15 (IMRT) and 1.69 ( conTFRT). For both indices, IMRT was more effective than VMAT (p=0.009, p=0.002). Dmean and V20 for ipsilateral lung were lower for IMRT than VMAT (p0.0001, p=0.003). Dmean, V2 and V5 of contralateral lung were lower for IMRT than VMAT (p.0.0001, p50.005). Mean dose and V5 to the heart were lower for IMRT than for VMAT (p=0.015, p=0.002). Conclusion: The hypothesis of equivalence of VMAT to IMRT was not confirmed for planning target volume parameter or dose distribution to organs at risk. VMAT was inferior to IMRT and 3D-CRTwith regard to dose distribution to organs at risk, especially at the low dose level. Advances in knowledge: New technology VMAT is not superior to IMRT or conventional radiotherapy in breast cancer in any aspect.
机译:目的:检验容积调制弧光疗法(VMAT)在乳腺癌中的可行性,并将其与三维正形放射疗法(contradion field radithetheraography,conTFRT)作为三维保形放射疗法(3D-CRT)进行比较。方法:12例患者(第1阶段,第8阶段:左乳腺癌6例,第2阶段右乳腺癌;第2阶段,第4阶段:每侧2例)。保乳手术后为每个病例计算了三个计划。锁骨上淋巴结包埋的4例患者和50例无淋巴结包涵的患者用50Gy治疗。测量了多个指标和剂量参数。结果:任何方式均未达到V95%。异质性指数:0.16(VMAT),0.13 [强度调制放射疗法(IMRT)]和0.14(conTFRT)。合格指数:1.06(VMAT),1.15(IMRT)和1.69(conTFRT)。对于这两个指标,IMRT比VMAT更有效(p = 0.009,p = 0.002)。 IMRT的同侧肺的Dmean和V20低于VMAT(p> 0.0001,p = 0.003)。 IMRT的对侧肺Dmean,V2和V5低于VMAT(p.0.0001,p50.005)。 IMRT的平均剂量和到达心脏的V5低于VMAT(p = 0.015,p = 0.002)。结论:VMAT与IMRT等效的假设尚未得到证实,无法用于计划目标体积参数或剂量分配给处于危险中的器官。就风险器官的剂量分布而言,VMAT不如IMRT和3D-CRT,尤其是在低剂量水平下。知识进步:在乳腺癌的任何方面,新技术VMAT都不比IMRT或常规放疗好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号